Peptide Future advanced
Peptide Immunotherapy: Oligopeptide Research Reference
Peptide-based approaches to modulate immune responses in cancer and autoimmune diseases. This peptide or oligopeptide is studied for its biological activity,...
By Encyclopeptide Editorial | 1 min read
immunotherapy cancer vaccine t-cell
Overview
Peptide immunotherapy uses synthetic peptides to activate or suppress specific immune responses for therapeutic benefit.
Approaches
- Cancer vaccines: Neoantigen and tumor-associated antigen peptides
- Checkpoint modulation: Peptide inhibitors of PD-1/PD-L1
- Tolerance induction: Peptides for autoimmune desensitization
- Allergen immunotherapy: Modified allergen peptides
Clinical Programs
- ISA101 for HPV-associated cancers
- UV1 for melanoma
- ATX-MS-1467 for multiple sclerosis
- Personalized neoantigen vaccines in trials
Future Directions
Combining peptide vaccines with checkpoint inhibitors and personalized neoantigen approaches represent the most promising strategies.
References
- Source: ENCP Peptide Database
- Category: Peptide Future
Test Your Knowledge
Reinforce what you learned about Peptide Immunotherapy: Oligopeptide Research Reference with interactive quizzes on Wikipept.
Take a Quiz on Wikipept